Shedding further light on disparities in, and the impact of discrimination on, kidney disease rates and care was the focus of a Kidney Week 2017 session titled “Context Is King: Neighborhood and Social Networks as a Risk Factor for Chronic Disease.”

Even with modern antiretroviral therapy (ART), survival on dialysis is significantly lower for non-white patients with HIV infection, according to a study in Kidney International.

The prevalence of diabetes is rapidly increasing and is projected to affect more than 400 million people by 2030 worldwide. Diabetic nephropathy remains the most serious microvascular complication and most frequent cause of end stage renal disease in the United States.

Understanding DNA has helped science make major strides in understanding and treating disease.

Intensive home hemodialysis (IHHD) has become an apparent alternate treatment option for ESRD patients with several clinical benefits.

What in your field hasn’t changed? What could be improved? What could be made less invasive? The impetus to improve on the way we currently do things will be a driving force in 2018.


Treatment with angiotensin-converting enzyme (ACE) inhibitors, statins, or both does not affect albumin excretion in adolescents with type 1 diabetes, concludes a trial in The New England Journal of Medicine.